European Archives - Page 291 of 1217 - European Medical Journal

Gut Bacteria Could Aid in Diagnosing PCOS Subtypes

A combined analysis of gut microbiota composition in patients with polycystic ovary syndrome (PCOS) identified distinct microbial patterns associated with PCOS subtypes, especially those differentiated by testosterone levels…

Rising Immunotherapy Use in Kidney and Bladder Cancer Highlights Disparities

Recent analysis from the National Cancer Database (NCDB) reveals a significant uptick in immunotherapy (IO) use for advanced kidney and bladder cancers….

Rifaximin Beats Lactulose in Preventing Hepatic Encephalopathy Recurrence: ACG 2024

Research presented at the American College of Gastroenterology (ACG) 2024 Annual Meeting showed that rifaximin monotherapy significantly reduces the risk of recurring overt hepatic encephalopathy

GLP-1 Drugs for Type 2 Diabetes Reduce Pancreatic Cancer Risk: ACG 2024

New research presented at the American College of Gastroenterology (ACG) Annual Meeting suggests that GLP-1 receptor agonists (GLP-1RAs) may significantly lower the risk of pancreatic cancer in patients with type 2 diabetes

Warning Issued as Scabies Cases Surge Across England

The Royal College of General Practitioners (RCGP) has reported a significant rise in scabies cases presenting at GP surgeries across England…

Long-Term Effects of Recurrent Rejection on Paediatric Heart Transplant Outcomes

Analysis of recurrent rejection (RR) in paediatric heart transplant recipients revealed that 17% of the population studied experienced RR.

24-Hour Antibiotic Course Prevents Infection Post-Cystectomy

A recent single-centre, randomised, trial has explored the effects of a 24-hour perioperative antibiotic course for patients undergoing cystectomy.

Air Pollution's Role in Rising Global Asthma Cases

Recent studies and meta-analyses have investigated the impact of PM2.5 on asthma, yet findings remain inconsistent.

AI Model Matches Radiologists in Detecting Chest X-Ray Abnormalities

A commercially available AI model has been found to perform on par with radiologists in detecting chest X-ray abnormalities.

Semaglutide Reduces Risk of Alzheimer’s Disease

Compared to other anti-diabetic drugs, semaglutide, also known as Ozempic, may lower the risk of Alzheimer’s disease in people with Type 2 diabetes (T2D).